The space between the 2 curves can actually plotted out to visually represent the clinical efficacy profile of the drug. Assuming a threshold of clinical efficacy exists, an empirical therapeutic 'window' may be identified, within which we can try and keep drug concentrations for optimal efficacy. I personally do not like the term window as it suggests the best approach might be to target the middle of that 'window'. I prefer 'therapeutic range' because the therapeutic strategy might actually be to exploit the range of concentrations so as to maximize the efficacy for the individual patient.
The shape of the clinical efficacy plot obviously will depend on the shape of the individual beneficial and toxicity curves. Likewise the therapeutic range will depend on the acceptable threshold of clinical efficacy for that specific drug.
No comments:
Post a Comment